About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Ezetimibe / rosuvastatin
- Procedure number
- PSUSA/00010271/202007
- Regulatory outcome
- Variation
Documents
Ezetimibe / rosuvastatin: List of nationally authorised medicinal products - PSUSA/00010271/202007
English (EN) (904.23 KB - PDF)
Ezetimibe / rosuvastatin: CMDh scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010271/202007
English (EN) (128.84 KB - PDF)
български (BG) (111.32 KB - PDF)
español (ES) (50.96 KB - PDF)
čeština (CS) (151.95 KB - PDF)
dansk (DA) (188.71 KB - PDF)
Deutsch (DE) (227.67 KB - PDF)
eesti keel (ET) (65.76 KB - PDF)
ελληνικά (EL) (257.75 KB - PDF)
français (FR) (102.93 KB - PDF)
hrvatski (HR) (193.12 KB - PDF)
italiano (IT) (23.21 KB - PDF)
latviešu valoda (LV) (126.73 KB - PDF)
lietuvių kalba (LT) (143.8 KB - PDF)
magyar (HU) (51.68 KB - PDF)
Malti (MT) (272.11 KB - PDF)
Nederlands (NL) (136.03 KB - PDF)
norsk (NO) (48.06 KB - PDF)
polski (PL) (226.61 KB - PDF)
português (PT) (121.92 KB - PDF)
română (RO) (139.38 KB - PDF)
slovenčina (SK) (146 KB - PDF)
slovenščina (SL) (107.72 KB - PDF)
Suomi (FI) (182.32 KB - PDF)
svenska (SV) (51.31 KB - PDF)